| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |